Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

Gevaert, Philippe, Van Bruaene, Nicholas, Cattaert, Tom, Van Steen, Kristel, Van Zele, Thibaut, Acke, Frederic, De Ruyck, Natalie, Blomme, Katrien +3 more·2011·Journal of Allergy and Clinical Immunology
DOI 10.1016/j.jaci.2011.07.056

Cited by (629)

Items 101–200 of 629

  1. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis
    Alexander Rivero, Jonathan Zhen Liang · 2017 · Annals of Otology Rhinology & Laryngology
  2. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase
    Jin‐Young Min, Christopher Joseph Ocampo, Whitney W. Stevens, Caroline P.E. Price, Christopher F. Thompson, Tetsuya Homma, Julia He Huang, James E. Norton, Lydia A. Suh, Kathryn L. Pothoven et al. · 2016 · Journal of Allergy and Clinical Immunology
  3. Biomarkers in Chronic Rhinosinusitis with Nasal Polyps
    Alan D. Workman, Michael A. Kohanski, Noam A. Cohen · 2018 · Immunology and Allergy Clinics of North America
  4. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
    Aikaterini Detoraki, Eugenio Tremante, Maria D’Amato, Cecilia Calabrese, Claudia Casella, Mauro Maniscalco, Remo Poto, Raffaele Brancaccio, Matilde Boccia, Maria Martino et al. · 2021 · Therapeutic Advances in Respiratory Disease
  5. Position Paper on Nasal Obstruction: Evaluation and Treatment
    SEAIC Rhinoconjunctivitis Committee & SEORL Rhinology, Allergy, and Skull Base Committee, Valero, A, Navarro, AM, del Cuvillo, A, Alobid, I, Benito, JR, Colás, C, de los Santos, G, Fernández Liesa, R, García-Lliberós, A et al. · 2018 · Journal of Investigational Allergology and Clinical Immunology
  6. 15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation
    Zhipeng Li, Ming Zeng, Yanhan Deng, Jinming Zhao, Xiuxia Zhou, John B. Trudeau, Ezequiel Goldschmidt, John A. Moore, Hongwei Chu, Weitian Zhang et al. · 2019 · Journal of Allergy and Clinical Immunology
  7. Rhinosinusitis and Nasal Polyps in Aspirin-Exacerbated Respiratory Disease
    Joaquim Mullol, César Picado · 2012 · Immunology and Allergy Clinics of North America
  8. Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management
    Jordan L. Heath, Larry D. Hartzell, Claire Putt, Joshua L. Kennedy · 2018 · Current Allergy and Asthma Reports
  9. Leitlinie „Rhinosinusitis“ – Langfassung
    BA Stuck, Achim Georg Beule, Detmar Jobst, Ludger Klimek, Martin Laudien, Michael Lell, Thomas J. Vogl, Uwe Popert · 2017 · HNO
  10. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease
    Katherine R. Tuttle, Kathleen M. Buchheit, Tanya M. Laidlaw, Katherine N. Cahill · 2018 · The Journal of Allergy and Clinical Immunology In Practice
  11. Real‐life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA
    Sven Seys, Shana De Bont, Wytske Johanna Fokkens, Claus Bachert, Isam Alobid, Manuel S Bernal‐Sprekelsen, Leif Hilding Bjermer, Ina Callebaut, Lars‐Olaf Cardell, Sean Carrie et al. · 2020 · Allergy
  12. Aspirin-Exacerbated Respiratory Disease: Prevalence, Diagnosis, Treatment, and Considerations for the Future
    Joshua L. Kennedy, Ashley N. Stoner, Larry Borish · 2016 · American Journal of Rhinology and Allergy
  13. Mepolizumab: First Global Approval
    Gillian M. Keating · 2015 · Drugs
  14. State-of-the-art overview on biological treatment for CRSwNP
    Peter William Hellings, E.W.M. Verhoeven, Wytske Johanna Fokkens · 2021 · Rhinology Journal
  15. Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis
    Gwanghui Ryu, Dae Woo Kim · 2019 · Current Opinion in Allergy and Clinical Immunology
  16. Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease
    Hannah Wangberg, Samantha R. Spierling Bagsic, Lilliana Osuna, Andrew A. White · 2021 · The Journal of Allergy and Clinical Immunology In Practice
  17. Aspirin exacerbated respiratory disease: Current topics and trends
    José Carlos Rodríguez-Jiménez, F.J. Moreno Paz, Luis Manuel Teran, Eduardo Guaní-Guerra · 2018 · Respiratory Medicine
  18. Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis
    Giorgio Walter Canonica, Tim W Harrison, Pascal Chanez, Francesco Menzella, Renaud E. Louis, Borja G. Cosío, Njira Lucia Lugogo, Arjun Mohan, Annie Burden, Esther García Gil · 2021 · Allergy
  19. Superior turbinate eosinophilia correlates with olfactory deficit in chronic rhinosinusitis patients
    Jennifer M. Lavin, Jin‐Young Min, Alcina K. Lidder, Julia He Huang, Atsushi Kato, Kent K. Lam, Eric K. Meen, Joan Sander Chmiel, James Norton, Lydia A. Suh et al. · 2017 · The Laryngoscope
  20. Asthma and Chronic Rhinosinusitis: Diagnosis and Medical Management
    Landon J. Massoth, Cody Anderson, Kibwei A. McKinney · 2019 · Medical Sciences
  21. Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art
    Lei Ren, Nan Zhang, Luo Zhang, Claus Bachert · 2019 · World Allergy Organization Journal
  22. Allergic rhinitis, chronic rhinosinusitis and asthma
    Harsha H. Kariyawasam, Giuseppina Rotiroti · 2012 · Current Opinion in Otolaryngology & Head & Neck Surgery
  23. Nasal mucus proteome and its involvement in allergic rhinitis
    Peter Valentin Tomazic, Barbara Darnhofer, Ruth Birner‐Gruenberger · 2020 · Expert Review of Proteomics
  24. Biologics for chronic rhinosinusitis
    Lee‐Yee Chong, Patorn Piromchai, Steve Sharp, Kornkiat Snidvongs, Carl Martin Philpott, Claire L Hopkins, Martin J Burton · 2020 · Cochrane Database of Systematic Reviews
  25. Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis
    Alice Z. Maxfield, Lukas David Landegger, Christopher D. Brook, Ashton E. Lehmann, Adam P. Campbell, Regan W. Bergmark, Konstantina M. Stanković, Ralph B. Metson · 2017 · Otolaryngology
  26. Biologics and biomarkers for asthma, urticaria, and nasal polyposis
    Thomas B. Casale · 2017 · Journal of Allergy and Clinical Immunology
  27. Highlights in the advances of chronic rhinosinusitis
    Xinni Xu, Sietze Reitsma, De Yun Wang, Wytske Johanna Fokkens · 2021 · Allergy
  28. Asthma biologics
    Ali Doroudchi, Mohini Pathria, Brian D. Modena · 2019 · Annals of Allergy Asthma & Immunology
  29. Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian population
    Sung‐Woo Cho, Dae Woo Kim, Jeong‐Whun Kim, Chul Hee Lee, Chae‐Seo Rhee · 2017 · Asia Pacific Allergy
  30. Inflammatory Endotypes and Microbial Associations in Chronic Rhinosinusitis
    Michael Hoggard, Sharon Waldvogel‐Thurlow, Melissa Zoing, Kevin Chang, Fiona Jane Radcliff, Brett Wagner Mackenzie, Kristi Biswas, Richard George Douglas, Michael W. Taylor · 2018 · Frontiers in Immunology
  31. Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps
    Alison Gail Kartush, Jane K. Schumacher, Rachna Shah, Monica Oberoi Patadia · 2018 · American Journal of Rhinology and Allergy
  32. The eosinophil
    Bruce Scott Bochner · 2018 · Annals of Allergy Asthma & Immunology
  33. Chronic rhinosinusitis: the rationale for current treatments
    Nsangou T. Ghogomu, Robert C. Kern · 2016 · Expert Review of Clinical Immunology
  34. Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma
    Abhaya P. Trivedi, Ian Douglas Pavord, Mario Castro · 2016 · The Lancet Respiratory Medicine
  35. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
    George X. Papacharalampous, Jannis Constantinidis, Georgios Fotiadis, Nan Zhang, Claus Bachert, Michael Katotomichelakis · 2023 · International Forum of Allergy & Rhinology
  36. Surgical treatment for nasal polyposis: predictors of outcome
    Marko Grgić, Hrvoje Čupić, Livije Kalogjera, Tomislav Baudoin · 2015 · European Archives of Oto-Rhino-Laryngology
  37. Update on the management of chronic rhinosinusitis
    Devyani Lal, Cain · 2013 · Infection and Drug Resistance
  38. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
    Peter William Hellings, Cezmi A. Akdiş, Claus Bachert, Jean J. Bousquet, B. Pugin, Gwijde Flavius Jacobus Petrus Maria Adriaensen, R. Advani, Ioana Octavia Agache, Carlos Anjo, Rajesh Anmolsingh et al. · 2017 · Rhinology Journal
  39. Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study
    Stefania Gallo, Paolo Castelnuovo, Luca Spirito, Marta Feduzi, Veronica Seccia, Dina Visca, Antonio Spanevello, Erica Statuti, Manuela Latorre, Claudio Montuori et al. · 2022 · Journal of Personalized Medicine
  40. Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions
    Kristine A. Smith, Abigail Pulsipher, David A. Gabrielsen, Jeremiah A. Alt · 2018 · American Journal of Rhinology and Allergy
  41. Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions
    Peter G. Gibson, Charlene M. Prazma, Geoffrey Lowell Chupp, Eric Bradford, Mark S. Forshag, Stephen A. Mallett, Steve W. Yancey, Steven G. Smith, Elisabeth H. Bel · 2021 · Respiratory Research
  42. Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
    Kevin L. Li, Andrew Y. Lee, Waleed M. Abuzeid · 2019 · Medical Sciences
  43. What is the contribution of IgE to nasal polyposis?
    Claus Bachert, Marcus Maurer, Óscar Palomares, William W. Busse · 2021 · Journal of Allergy and Clinical Immunology
  44. Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD)
    Bruce Scott Bochner, Wendy Book, William W. Busse, Joseph H. Butterfield, Glenn T. Furuta, Gerald J. Gleich, Amy D. Klion, James J. Lee, Kristin M. Leiferman, Michael Minnicozzi et al. · 2012 · Journal of Allergy and Clinical Immunology
  45. Allergic Aspergillus Rhinosinusitis
    Arunaloke Chakrabarti, Harsimran Kaur · 2016 · Journal of Fungi
  46. Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
    Francesco Menzella, Mirco Lusuardi, Carla Galeone, Sofia Taddei, Luigi Zucchi · 2015 · Journal of Asthma and Allergy
  47. Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop
    Robert M. Naclerio, Fuad M. Baroody, Claus Bachert, Benjamin Saul Bleier, Larry Borish, Erica Brittain, Geoffrey Lowell Chupp, Anat Fisher, Wytske Johanna Fokkens, Philippe Gevaert et al. · 2020 · The Journal of Allergy and Clinical Immunology In Practice
  48. Key role of the epithelium in chronic upper airways diseases
    Sophie Gohy, Cloé Hupin, Maha Zohra Ladjemi, Valérie Hox, Charles Pilette · 2019 · Clinical & Experimental Allergy
  49. Biology and Function of Eosinophils in Chronic Rhinosinusitis With or Without Nasal Polyps
    Bruce Scott Bochner, Whitney W. Stevens · 2020 · Allergy Asthma and Immunology Research
  50. Mepolizumab for chronic rhinosinusitis with nasal polyps ( SYNAPSE ): In‐depth sinus surgery analysis
    Wytske Johanna Fokkens, Joaquim Mullol, David W. Kennedy, Carl Martin Philpott, Veronica Seccia, Robert C. Kern, André Coste, Ana R. Sousa, Peter Hugo Howarth, Victoria S. Benson et al. · 2022 · Allergy
  51. Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease
    Xin Feng, Madison K. Ramsden, Julie A. Negri, Mary Grace Baker, Spencer C. Payne, Larry Borish, John W. Steinke · 2016 · Journal of Allergy and Clinical Immunology
  52. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis
    Joseph K. Han, Claus Bachert, Stella E. Lee, Claire L Hopkins, Enrico Marco Heffler, Peter William Hellings, Anju Tripathi Peters, Siddhesh Kamat, D Whalley, Shanshan Qin et al. · 2021 · The Laryngoscope
  53. Cytokine Patterns and Endotypes in Acute and Chronic Rhinosinusitis
    Kathrin Scheckenbach, Martin Wagenmann · 2015 · Current Allergy and Asthma Reports
  54. Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys
    Katrin König, Christine Klemens, Mareike Haack, Marion San Nicoló, Sven Becker, Matthias F. Kramer, Moritz Gröger · 2016 · Allergy Asthma and Clinical Immunology
  55. Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
    Harsha H. Kariyawasam, Louisa Katherine James, Simon B. Gane · 2020 · Drug Design Development and Therapy
  56. Real-Life Experience of Monoclonal Antibody Treatments in Chronic Rhinosinusitis with Nasal Polyposis
    Eva C. Meier, Peter Schmid‐Grendelmeier, Urs Christian Steiner, Michael Soyka · 2021 · International Archives of Allergy and Immunology
  57. Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention
    Justin H. Turner, Ping Li, Rakesh Kumar Chandra · 2018 · International Forum of Allergy & Rhinology
  58. Phenotypes in Chronic Rhinosinusitis
    Justin P. McCormick, Harrison M. Thompson, Do‐Yeon Cho, Bradford Alan Woodworth, Jessica W. Grayson · 2020 · Current Allergy and Asthma Reports
  59. Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis
    William Eschenbacher, Matthew D. Straesser, Alice Knoedler, Rung‐chi Li, Larry Borish · 2020 · Immunology and Allergy Clinics of North America
  60. Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?
    Andrea Matucci, Susanna Bormioli, Francesca Nencini, Fabio Chiccoli, Emanuele Vivarelli, Enrico Maggi, Alessandra Vultaggio · 2021 · International Journal of Molecular Sciences
  61. Update on the Management of Aspirin-Exacerbated Respiratory Disease
    Kathleen M. Buchheit, Tanya M. Laidlaw · 2016 · Allergy Asthma and Immunology Research
  62. Personalized Medicine in Allergy
    Matteo Ferrando, Diego Bagnasco, Gilda Varricchi, Stefano Bernardi, Alice Bragantini, Giovanni Passalacqua, Giorgio Walter Canonica · 2016 · Allergy Asthma and Immunology Research
  63. New concepts in asthma: clinical phenotypes and pathophysiological mechanisms
    Andreas Rembert Koczulla, Claus Franz Vogelmeier, Holger Garn, Harald E. Renz · 2016 · Drug Discovery Today
  64. Staphylococcus Aureus in chronic airway diseases: An overview
    Martina Flora, Fabio Perrotta, Ambra Nicolai, Rosalba Maffucci, Anna Pratillo, Mariano Mollica, Andrea Bianco, Cecilia Calabrese · 2019 · Respiratory Medicine
  65. Non-Eosinophilic Nasal Polyps Shows Increased Epithelial Proliferation and Localized Disease Pattern in the Early Stage
    Dong‐Kyu Kim, Hong Ryul Jin, Kyoung Mi Eun, Somasundran Mutusamy, Seong H. Cho, Sohee Oh, Dae woo Kim · 2015 · PLoS ONE
  66. Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps
    Sevilay Hançer Tecimer, Fikret Kasapoğlu, U Demir, Ömer Afşın Özmen, Hakan H. Coskun, Oğuz Basut · 2014 · European Archives of Oto-Rhino-Laryngology
  67. Role of Eosinophil Granulocytes in Allergic Airway Inflammation Endotypes
    Kawa Amin, C. Janson, Jonas Byström · 2016 · Scandinavian Journal of Immunology
  68. Chronic rhinosinusitis phenotypes
    John W. Steinke, Larry Borish · 2016 · Annals of Allergy Asthma & Immunology
  69. Autophagy deficiency in myeloid cells exacerbates eosinophilic inflammation in chronic rhinosinusitis
    Go Eun Choi, Seung‐Yong Yoon, Jiyun Kim, Do‐Young Kang, Yong Ju Jang, Hun Sik Kim · 2017 · Journal of Allergy and Clinical Immunology
  70. Pediatric Versus Adult Chronic Rhinosinusitis
    Kornkiat Snidvongs, Melissa Sangubol, Orapan Poachanukoon · 2020 · Current Allergy and Asthma Reports
  71. Pharmacological Management of Allergic Rhinitis: A Consensus Statement from the Malaysian Society of Allergy and Immunology
    Baharudin Abdullah, Amir Hamzah Abdul Latiff, Anura Michelle Manuel, Faizah Mohamed Jamli, Harvinder Singh, Intan Hakimah Ismail, Jahendran Jeevanan, Jeyasakthy Saniasiaya, Kent Woo Kee Chen, Phaik Choo Khoo et al. · 2022 · Journal of Asthma and Allergy
  72. Emerging biologics for the treatment of chronic rhinosinusitis
    Bauke Pauwels, Karin Jonstam, Claus Bachert · 2015 · Expert Review of Clinical Immunology
  73. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease
    Jeong‐Hee Choi, Mi‐Ae Kim, Hae‐Sim Park · 2013 · Current Opinion in Allergy and Clinical Immunology
  74. Stratified approaches to the treatment of asthma
    Stephen T. Holgate · 2012 · British Journal of Clinical Pharmacology
  75. JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps
    Tsuguhisa Nakayama, Naoki Sugimoto, Naoko Okada, Tadao Tsurumoto, Ryoto Mitsuyoshi, Shinya Takaishi, Daiya Asaka, Hiromi Kojima, Mamoru Yoshikawa, Yasuhiro Tanaka et al. · 2018 · Auris Nasus Larynx
  76. Eosinophils in the Field of Nasal Polyposis: Towards a Better Understanding of Biologic Therapies
    Thibault Vanderhaegen, Isabelle M. Gengler, Arnaud Dendooven, Cécile Chenivesse, Guillaume Lefèvre, G. Mortuaire · 2021 · Clinical Reviews in Allergy & Immunology
  77. Trials and tribulations in identifying new biologic treatments for asthma
    Stephen T. Holgate · 2012 · Trends in Immunology
  78. Chronic rhinosinusitis and emerging treatment options
    Patorn Piromchai, Kasemsiri, Laohasiriwong, Thanaviratananich · 2013 · International Journal of General Medicine
  79. Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis
    Diego Bagnasco, Luisa Brussino, Marco Bonavia, Elisa Calzolari, Marco Caminati, Cristiano Caruso, Maria D’Amato, Laura De Ferrari, Fabiano Di Marco, Gianluca Imeri et al. · 2020 · Respiratory Medicine
  80. Role of Medical Therapy in the Management of Nasal Polyps
    Isam Alobid, Joaquim Mullol · 2012 · Current Allergy and Asthma Reports
  81. Aspirin-exacerbated respiratory disease and current treatment modalities
    Emine Şakalar, Nuray Bayar Muluk, Murat Kar, Cemal Cingi · 2016 · European Archives of Oto-Rhino-Laryngology
  82. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media
    Yukiko Iino, Eri Takahashi, Saeko Ida, Saori Kikuchi · 2018 · Auris Nasus Larynx
  83. Noninvasive exosomal proteomic biosignatures, including cystatin SN, peroxiredoxin‐5, and glycoprotein VI, accurately predict chronic rhinosinusitis with nasal polyps
    Sarina K. Mueller, Angela L. Nocera, Simon T. Dillon, Xuesong Gu, Olaf Wendler, Hasan H. Otu, Towia A. Libermann, Benjamin Saul Bleier · 2018 · International Forum of Allergy & Rhinology
  84. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis
    William C. Brown, Brent Anthony Senior · 2020 · Current Allergy and Asthma Reports
  85. Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options
    Claus Bachert, Gabriële Holtappels · 2015 · PubMed Central
  86. Cytokine-targeting biologics for allergic diseases
    Monica G. Lawrence, John W. Steinke, Larry Borish · 2018 · Annals of Allergy Asthma & Immunology
  87. Canadian Rhinology Working Group consensus statement: Biologic therapies for chronic rhinosinusitis
    Andrew Vernu Thamboo, Shaun Kilty, Ian Witterick, Yvonne Chan, Christopher Joseph Chin, Arif S. Janjua, Amin R. Javer, Joseph Lee, Eric Monterio, Brian W. Rotenberg et al. · 2021 · Journal of Otolaryngology - Head and Neck Surgery
  88. Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
    Raj H. Sindwani · 2012 · Yearbook of Otolaryngology-Head and Neck Surgery
  89. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps
    Els L. L. M. de Schryver, Lara Derycke, Lien Calus, Gabriële Holtappels, Peter William Hellings, Thibaut Van Zele, Claus Bachert, Philippe Gevaert · 2017 · Rhinology Journal
  90. Pathophysiological and Clinical Aspects of Chronic Rhinosinusitis: Current Concepts
    Stephan Vlaminck, Frederic R. E. Acke, Glenis Kathleen Scadding, Bart N. Lambrecht, Philippe Gevaert · 2021 · Frontiers in Allergy
  91. Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis
    Harsha H. Kariyawasam, Deepak P. Chandrasekharan, T Jacques, Patrick Joe Stokes, Magdalena Dziadzio, Simon B. Gane, Dean Langan, Joanne Rimmer · 2023 · Rhinology Journal
  92. Therapeutic antibodies: A new era in the treatment of respiratory diseases?
    Thomas Sécher, Laurent Guilleminault, Karen L. Reckamp, Idoroenyi Usua Amanam, Laurent Plantier, Nathalie Heuzé‐Vourc'h · 2018 · Pharmacology & Therapeutics
  93. Aspirin-exacerbated respiratory disease
    Hannah Wangberg, Andrew A. White · 2020 · Current Opinion in Immunology
  94. The role of biologics in chronic rhinosinusitis: a systematic review
    Isma Z. Iqbal, Stephen Shih‐Teng Kao, Eng Hooi Ooi · 2019 · International Forum of Allergy & Rhinology
  95. Highly multiplexed proteomic analysis reveals significant tissue and exosomal coagulation pathway derangement in chronic rhinosinusitis with nasal polyps
    Sarina K. Mueller, Angela L. Nocera, Simon T. Dillon, Dawei Wu, Towia A. Libermann, Benjamin Saul Bleier · 2018 · International Forum of Allergy & Rhinology
  96. Endotype-driven precision medicine in chronic rhinosinusitis
    Hongfei Lou, Chengshuo Wang, Luo Zhang · 2019 · Expert Review of Clinical Immunology
  97. Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps
    Rory Chan, Chris RuiWen Kuo, Brian Jonathon Lipworth · 2020 · The Journal of Allergy and Clinical Immunology In Practice
  98. Benefits of biologic therapy administered for asthma on co‐existent chronic rhinosinusitis: A real‐world study
    Shilpika Bajpai, Michael J. Marino, Matthew A. Rank, Angela M. Donaldson, Erin K. O’Brien, Devyani Lal · 2021 · International Forum of Allergy & Rhinology
  99. Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets
    Junhu Tai, Mun Soo Han, Tae Hoon Kim · 2022 · International Journal of Molecular Sciences
  100. Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis
    Angela L. Nocera, Sarina K. Mueller, Alan D. Workman, Dawei Wu, Kristen McDonnell, Peter M. Sadow, Mansoor M. Amiji, Benjamin Saul Bleier · 2022 · Journal of Allergy and Clinical Immunology